Buprenorphine Pharmacology Related to Addiction Treatment - 18
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00000236
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug use Psychological changes in: pupil diameter, blood pressure, heart rate, respiration Opioid agonist effects Opiate withdrawal
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Treatment Research Center
🇺🇸Burlington, Vermont, United States
Treatment Research Center🇺🇸Burlington, Vermont, United States